Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology

Journal of Cellular Physiology

Volumn 226, Issue 9, 2011, Pages 2213-2214

  Barba, Maddalena ^a   Felsani, Armando ^b   Rinaldi, Massimo ^a   Giunta, Salvatore ^a   Malorni, Walter ^c,d   Paggi, Marco G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Istituto San Raffaele Sulmona   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MOLECULAR MARKER; UNTRANSLATED RNA;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; HIGH RISK POPULATION; HUMAN; LUNG CANCER; LUNG NODULE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RISK REDUCTION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MICRORNAS; MOLECULAR BIOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 79958759916     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22558     Document Type: Article

References (34)

1. Bach PB. 2008a. Is our natural-history model of lung cancer wrong? Lancet Oncol 9: 693-697.
2. Bach PB. 2008b. Overdiagnosis in lung cancer: Different perspectives, definitions, implications. Thorax 63: 298-300.
3. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. 2007. Computed tomography screening and lung cancer outcomes. JAMA 297: 953-961.
4. Baker M. 2010. MicroRNA profiling: Separating signal from noise. Nat Methods 7: 687-692.
5. Beadsmoore CJ, Screaton NJ. 2003. Classification, staging and prognosis of lung cancer. Eur J Radiol 45: 8-17.
6. Bentwich I. 2005. Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910.
7. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. 2008. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
8. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K, Einstein AJ, Nallamothu BK. 2009. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 361: 849-857.
9. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. 2006. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355: 1763-1771.
10. Herbst RS, Heymach JV, Lippman SM. 2008. Lung cancer. N Engl J Med 359: 1367-1380.
11. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. 2010. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
13. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E. 2009. miRNAs in lung cancer-Studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353.
14. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M. 2009. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030-2037.
15. Lee YS, Dutta A. 2009. MicroRNAs in cancer. Annu Rev Pathol 4: 199-227.
16. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. 2009. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 4: e6229.
17. Marshall E. 2010. The promise and pitfalls of a cancer breakthrough. Science 330: 900-901.
18. Nelson KM, Weiss GJ. 2008. MicroRNAs and cancer: Past, present, and potential future. Mol Cancer Ther 7: 3655-3660.
19. Osaki M, Takeshita F, Ochiya T. 2008. MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13: 658-670.
20. Paggi MG, Vona R, Abbruzzese C, Malorni W. 2010. Gender-related disparities in non-small cell lung cancer. Cancer Lett 298: 1-8.
21. Ranade AR, Cherba D, Sridhar S, Richardson P, Webb C, Paripati A, Bowles B, Weiss GJ. 2010. MicroRNA 92a-2*: A biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 5: 1273-1278.
22. Reich JM. 2008. A critical appraisal of overdiagnosis: Estimates of its magnitude and implications for lung cancer screening. Thorax 63: 377-383.
23. Simpson RJ, Lim JW, Moritz RL, Mathivanan S. 2009. Exosomes: Proteomic insights and diagnostic potential. Expert Rev Proteomics 6: 267-283.
24. The National Lung Screening Trial Research Team. 2010. The national lung screening trial: Overview and study design. Radiology (November 30, 2010), DOI: 10.1148/radiol.10091808.
25. Tong AW. 2006. Small RNAs and non-small cell lung cancer. Curr Mol Med 6: 339-349.
26. Toyoda Y, Nakayama T, Kusunoki Y, Iso H, Suzuki T. 2008. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer 98: 1602-1607.
27. Wang QZ, Xu W, Habib N, Xu R. 2009. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 9: 572-594.
28. Welch HG, Black WC. 2010. Overdiagnosis in cancer. J Natl Cancer Inst 102: 605-613.
29. Welch HG, Woloshin S, Schwartz LM, Gordis L, Gotzsche PC, Harris R, Kramer BS, Ransohoff DF. 2007. Overstating the evidence for lung cancer screening: The International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 167: 2289-2295.
30. Wu W, Sun M, Zou GM, Chen J. 2007. MicroRNA and cancer: Current status and prospective. Int J Cancer 120: 953-960.
31. Wu X, Piper-Hunter MG, Crawford M, Nuovo GJ, Marsh CB, Otterson GA, Nana-Sinkam SP. 2009. MicroRNAs in the pathogenesis of lung cancer. J Thorac Oncol 4: 1028-1034.
32. Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. 2010. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67: 170-176.
33. Xu DM, van Klaveren RJ, de Bock GH, Leusveld A, Zhao Y, Wang Y, Vliegenthart R, de Koning HJ, Scholten ET, Verschakelen J, Prokop M, Oudkerk M. 2008. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial. Eur J Radiol 68: 347-352.
34. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.